Search
SOLACI Congress
HomeCONGRESSInternational Congresses

International Congresses

View Category
Day 1

PRAGUE 13 trial

Fundamentos e objetivos: A intervenção coronária percutânea (PCI) primária da artéria culpada pelo infarto agudo do miocárdio...
solaci -
Learn More
Day 2

TOTAL OCT: Thrombotic load of culprit lesion using OCT. TOTAL substudy.

The thrombotic load of culprit lesion is unidentified in the context of acute myocardial infarction that vindicates...
solaci -
Learn More
Day 2

OPINION: optical frequency domain versus IVUS to guide angioplasty

This multicenter, prospective, randomized controlled study was designed to evaluate the noninferiority of guided angioplasty by optical...
solaci -
Learn More
Day 2

CoreValve Evolut R CE: Good results at 6 months of the new CoreValve repositionable

This study evaluated the safety and efficacy of the new repositionable self-expanding valve. The primary end point...
solaci -
Learn More
Day 2

BVS-STEMI-FIRST OCT study: Bioabsorbable platform in acute myocardial infarction

A bioabsorbable platform implant in the context of ST segment elevation acute myocardial infarction is feasible although...
solaci -
Learn More
Day 2

ADVANCE II CoreValve Trial: Results at six months of self-expanding aortic valve

The CoreValve ADVANCE II Trial is a research study of the best practices to implement this device....
solaci -
Learn More
Day 2

ILUMIEN II: OCT guided stenting versus IVUS

The main predictor of adverse outcomes (thrombosis and restenosis) after implantation of a stent is the degree...
solaci -
Learn More
Day 2

SAPIENS 3: Favorable outcomes with TAVI in intermediate risk patients

Transcatheter aortic valve replacement is a safe and effective alternative to surgery in patients with severe aortic...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy